Saquayamycin B1

Saquayamycin B1 has antimicrobial effect, but it has weaker effect against Gram-negative bacteria. Saquayamycin B1 has inhibitory effect on leukemia P388 cells and Adriamycin-resistant P388 cells[1].

Product Specifications

CAS Number

[99260-68-1]

UNSPSC

12352005

Target

Bacterial

Related Pathways

Anti-infection

Field of Research

Cancer; Infection

Smiles

O=C1C[C@](C)(O)C[C@]2(O)[C@@]1(O)C(C(C3=CC=C([C@H]4C[C@@]5([H])O[C@](CC([C@H](C)O6)=O)([H])[C@]6([H])O[C@]5([H])[C@@H](C)O4)C(O)=C3C7=O)=O)=C7C=C2

Molecular Formula

C31H32O12

Molecular Weight

596.58

References & Citations

[1]Jianjiang Li, et al. Saquayamycin B1 Suppresses Proliferation, Invasion, and Migration by Inhibiting PI3K/AKT Signaling Pathway in Human Colorectal Cancer Cells. Mar Drugs. 2022 Sep 7;20 (9) :570.